Market Overview

Cell Therapeutics Receives Remaining $5 million Under Existing Loan Financing Agreement


Cell Therapeutics (NASDAQ: CTIC) today announced that CTI has received the remaining $5 million from Hercules Technology Growth Capital, Inc. (NYSE: HTGC) available under the existing loan agreement that was established in March 2013.  Further information with respect to this loan with Hercules will be available in a Current Report on Form 8-K that will be filed by CTI with the Securities and Exchange Commission. 

See full press release

Posted-In: News Guidance Financing Management Global


Related Articles (CTIC + HTGC)

View Comments and Join the Discussion!

Opexa Therapeutics Prices 4.12M Share Offering at $1.70/Share

Cellcom Israel Announces Court Approves Creditor's Arrangement for IDBH